Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Congressional Testimony

Congressional Testimony

                        Congressional Testimony 2018 - 2019
          Congressional Testimony  2017
          Congressional Testimony 2016 Home
          News & Events
          Congressional Testimony
          Congressional Testimony 2016Congressional Testimony Congressional Testimony 2016
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThis section includes testimony by FDA officials before House and Senate Committees and Subcommittees.

December 2016

12/07/2016: Waste and Duplication in the USDA Catfish Inspection Program 
	William R. Jones, Ph. D, before the Committee on Energy and Commerce, U.S. House of RepresentativesSeptember 2016

09/22/2016: Exploring a Right to Try for Terminally Ill Patients 
	Peter Lurie, M.D., M.P.H., before the Committee on Homeland Security and Government Affairs, U.S. Senate
	09/21/2016: Reviewing the Rising Price of EpiPens 
	Douglas Throckmorton, M.D., before the Committee on Oversight and Government Reform, U.S. House of Representatives
	09/21/2016: Prioritizing Public Health: The FDAâs Role in the Generic Drug Marketplace 
	Janet Woodcock, M.D., before the Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Committee on Appropriations; U.S. SenateJuly 2016

07/13/2016: Researching the Potential Medical Benefits and Risks of Marijuana 
	Douglas Throckmorton, M.D., before the Committee on the Judiciary, U.S. SenateJune 2016

06/14/2016: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development 
	Janet Woodcock, M.D. before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
	06/07/2016: Deadly Synthetic Drugs: The Need to Stay Ahead of the Poison Peddlers 
	Douglas Throckmorton, M.D., before the Committee on the Judiciary, U.S. SenateMay 2016

05/19/2016: Strengthening Public Health Emergency Response Act of 2015 
	Michael Mair, MPH, before the House Subcommittee on Health, Committee on EnergyApril 2016

04/20/2016: How Secure are U.S. Bioresearch Labs? Preventing the Next Safety Lapse 
	Segaran Pillai, Ph.D., before the House Energy and Commerce Committee, Subcommittee on Oversight and InvestigationsMarch 2016

03/02/2016: Examining the U.S. Public Health Response to the Zika Virus 
	Luciana Borio, M.D., before the House Energy and Commerce Committee, Subcommittee on Oversight and Investigations
	03/02/2016: President's Fiscal Year 2017 Budget Request (Senate) 
	Robert Califf, M.D., before the Senate Appropriations Committee, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesFebruary 2016

02/25/2016: President's Fiscal Year 2017 Budget Request (House) 
	Stephen Ostroff, M.D., before the Committee on Appropriations; Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; U.S. House of Representatives
	02/04/2016: Biosimilars Implementation 
	Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health
	02/04/2016: Implementation of the Generic Drug User Fee Amendments of 2012 (GDUFA) 
	Janet Woodcock, M.D., before the House Committee on Oversight and Government ReformJanuary 2016

01/28/2016: Implementation of the Generic Drug User Fee Amendments of 2012 (GDUFA) 
	Janet Woodcock, M.D., before the Senate Committee on Health, Education, Labor and Pensions

                                                                                  Content current as of:
      02/13/2019Congressional Testimony

          
                        Congressional Testimony 2018 - 2019
          Congressional Testimony  2017
          Congressional Testimony 2016
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop